What Is Teeka Tiwari’s 3rd Trillion Dollar Trade?

Hello, and thanks for stopping by. Today we’re going to be looking into a presentation from Teeka Tiwari about his “3rd Trillion Dollar Trade.”

Teeka says that two of his previous “trillion dollar” predictions had to do with the internet and crypto, and have gone up roughly 32X and 151X respectively. And that his third one could give you the chance to make 100 years worth of stock market gains in just 18 months.

What’s it all about?

The 3rd Trillion Dollar Trade Summit is a presentation featuring Teeka Tiwari, John Burke, and Mike “Zappy” Zapolin that is all about investing in psychedelic medicine companies.

In the presentation, Teeka reveals one stock, Compass Pathways (CMPS), that he’s bullish on. But to access his other recommendations related to medical psychedelics, you need to join his service, Palm Beach Special Opportunities.

Let’s take a closer look at what his prediction is all about, the stocks Teeka is recommending, and what’s involved with joining his “Special Opportunities” service.

The 3rd Trillion Dollar Trade Summit

The 3rd Trillion Dollar Trade Summit presentation originally aired on July 8th, 2021, and for almost an hour and forty minutes, the main focus was on medical psychedelics.

The presentation kicked off as an interview between host John Burke and investor Teeka Tiwari of Palm Beach Research Group. Both of which I’ve come across before.

Teeka Tiwari is a successful investor who runs a popular newsletter called Palm Beach Letter, and John Burke has interviewed a number of investing gurus about their investing programs. Like Ian King with New Era Fortunes and Tom Gentile with his presentation about Cannabis Lots.

Anyway, later in the presentation, a man named Mike Zapolin (AKA Zappy) was introduced, who I have not heard of before, and apparently he’s an expert on psychedelics.

At that point, both Teeka and Mike began discussing the huge potential opportunity involved with psychedelic medicine for 2021 and beyond.

Specifically, they talked about the opportunity around investing in companies that are at the forefront of this sector. And how Teeka believes this could be the next “mega trend” and give everyday investors the chance to make a lot of money.

Long story short, Teeka says we could be witnessing the birth of the next potential trillion-dollar industry. And that he has his eye on the stocks that could soar when it takes off.

But psychedelics… really?

I’m not an expert on the topic of psychedelics, but that is at the heart of Teeka’s third trillion dollar prediction. His previous two predictions involved Apple in 2003 and Bitcoin in 2016, both of which he (and those who listened to him) would likely have done extremely well with.

In any case, during the presentation, Teeka and Mike discuss the potential medical uses of psychedelics to treat things like anxiety, addiction, and post traumatic stress disorder (PTSD). And how psychedelics are in the midst of being rescheduled in the United States.

What does “rescheduled” mean?

Well, from what I understand, psychedelics are currently listed as a schedule 1 drug in the United States at the federal level, which basically means they’re not legal.

However, Mike and Teeka point out that this could soon change, and that if/when it does, lots of innovation could start taking place and large institutions could start investing. Which they say could present a massive opportunity for those who get in early.

Is there any substance to this?

Well as I mentioned, I’m not an expert on psychedelics. So I can’t say for sure what the benefits of psychedelics are, what the future holds with respect to legalization in the U.S., or how potentially lucrative of an opportunity this could be.

What I can say, however, is the following:

• There have been studies regarding the potential benefits of psychedelics (see the previous link) and it does look like an interesting and evolving space.
• There are companies jumping on the psychedelics bandwagon, innovating and getting in front of this potential trend (more on this in a moment).
• There does appear to be at least some momentum with respect to legalizing psychedelics for medical use in the United States. For example, according to Wikipedia, an initiative to legalize medical psilocybin (a type of psychedelic) was approved by voters in the state of Oregan on November 3, 2020.
• Mike Zapolin is renowned psychedelics guru, and Teeka Tiwari is a successful investor who’s known for getting ahead of some of the biggest trends (internet and crypto) in the world.

Does that mean investing in companies in the medical psychedelic space is guaranteed to be a “historic opportunity” to make 100 years worth of stock market gains in 18 months or less?

Maybe, but there are no guarantees.

Either way, it does look like an interesting opportunity, and given Teeka’s track record, I wouldn’t rule out the possibility of making money from some of his predictions.

What Is Teeka’s Trillion Dollar Trade?

Unlike Teeka Tiwari’s first two “trillion dollar” trades, his third idea is not about any one company, instead, it’s more of a bet on an emerging industry – medical psychedelics.

That said, during the “3rd Trillion Dollar Trade” presentation, he does share the name and ticker symbol of ONE company he’s interested in. And he talks about “5 stocks set to dominate the psychedelic medicine space in 2021” and a “trillion dollar pre-IPO company” he’s interested in.

What stock does he mention in the presentation?

The name of the company he recommends in the presentation is Compass Pathways (CMPS) which, according to the website, is a “mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.”

In the presentation, Mike Zapolin states that Compass Pathways has FDA approval for a synthetic form of psilocybin (psychedelic mushroom) for treatment-resistant depression.

Really?

Yup. I checked, and that claim does appear to be truthful. According to a statement made by the company in a press release on globenewswire.com:

We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD)

So, long story short, Compass Pathways is part of Teeka’s 3rd Trillion Dollar Trade prediction. And it looks like an interestin company.

What other companies does he recommend?

In the presentation, Teeka says he has his eye on six companies right now, and that he’s regularly looking for other companies to share with his subscribers each month.

How do you access Teeka’s stock picks?

To access Teeka’s stock picks, you need to join his service, Palm Beach Special Opportunities, for $2K. As a subscriber, you get access to two special reports which detail his picks.

The first report is titled “The Trillion-Dollar Trade Portfolio” which details five stocks that Teeka says are set to dominate the psychedelic medicine space in 2021.

And the second report is titled “The Trillion-Dollar Pre-IPO” which details a pre-IPO company that Mike and Teeka are bullish on.

What’s a pre-IPO company?

It’s basically a company that hasn’t gone public yet. And as this article on Investopedia explains, investing in a pre-IPO company involves buying shares of the company before its Initial Public Offering. Or in other words, before it goes public.

According to the presentation, members of Palm Beach Special Opportunities get these two reports that contain Teeka and Mike’s six psychedelic stock picks, as well as a new recommendations each and every month.

Let’s take a closer look at what this is about and how it works.

What’s Palm Beach Special Opportunities?

Palm Beach Special Opportunities is an investment advisory service published by Palm Beach Research Group.

According to the Palm Beach Research Group website, there are two main goals of the service: to be early and to be right. So it’s mostly focussed on smaller stocks with huge upside potential.

And that there are two main ways the service aims to achieve that goal:

• The first is to find massive, trillion-dollar trends in their early stages
• And the second is about developing a network of industry experts

In this case, the industry the service is targeting is the “$3 trillion global mental health disorder epidemic.” Or, more specifically, medicinal psychedelics. And that the main industry expert that Teeka is working with to gain insight into this industry, is Mike Zapolin (Zappy).

What do you get if you join?

As a subscriber of Palm Beach Special Opportunities (AKA Special Ops), Teeka Tiwari, Mike Zapolin and William Mikula provide you with a new stock pick and detailed analysis each month as part of the monthly issues. As of writing, each new stock pick is related to medicinal psychedelics, and you get a detailed breakdown of each recommendation.

You also get access to the Palm Beach Special Opportunities Model Portfolio which shows you all of Teeka’s current recommendations, and the following two special reports:

• The Trillion-Dollar Trade Portfolio (5 psychedelics-related stock picks)
• The Trillion-Dollar Pre-IPO (1 psychedelics-related pre-IPO recommendation)

How much does it cost to join?

The cost of joining Palm Beach Special Opportunities is $4,000 for 12 months. However, as part of Teeka’s “3rd Trillion Dollar Trade” presentation, you can join for $2,000 for 12 months.

Is there a guarantee?

There is no guarantee that you’ll make money by joining the service.

However, the website says it is possible to get a “credit refund” if you’re not happy with the service within 90 days. Which means you can request a credit to use on other services run by the company or other financial publishing companies they’re affiliated with like Brownstone Research, Casey Research, or Rogue Economics.

Who Is Teeka Tiwari?

Teeka Tiwari is a former hedge fund manager, and lead editor of popular investment advisory services (like Palm Beach Letter) that are published by Palm Beach Research Group.

Prior to working with Palm Beach Research Group, Teeka says he came to the United States when he was just 16 years old, with just $150 to his name.

Two years later, he says he became the youngest employee at Lehman Brothers, and two years after that, the youngest vice president of Shearson Lehman.

By age 23, Teeka says he was a millionaire.

It wasn’t all smooth sailing though. According to the Palm Beach Research Group website, at one point, he lost everything and filed for personal bankruptcy. But before long, the site says he rebuilt his wealth, started a successful hedge fund, and made risk management his top priority.

These days, Teeka is probably best-known for his work in the financial education space, and is arguably one of the most popular investing gurus out there.

And some of his picks have been pretty incredible.

For example, according to Legacy Research Group, Teeka’s “first trillion dollar trade” was when he recommended Apple to his clients in 2003. And his second was when he recommend Bitcoin in 2016, when it was trading at around $400.

So my point being, those who listened to him then could have done considerably well for themselves with those two recommendations alone. Of course, not everything he recommends is a winner, but he does have a track record of sharing great opportunities.

Who Is Mike “Zappy” Zapolin?

Mike “Zappy” Zapolin is not as well-known in the financial education space, but he does have a background in investing and is seen as a guru of plant-based medicine.

According to the Palm Beach Research Group website, he was the vice president of a prestigious investing firm in his early twenties, has made significant returns investing in early-stage medical psychedelic companies, and his work has been featured on Fox News, Business Insider, Good Morning America, and more.

The site also says he’s one of the “foremost experts in psychedelic and plant-based medicinal therapies and companies.” Which, based on my research, does seem to be the case.

According to this article on Insider, Zappy has served as a “psychedelics concierge” to celebrities and has been involved with documentaries relating to psychedelics.

Like “The Reality of Truth” for example.

So he does seem to be quite knowledgable when it comes to the plant-based medicine and psychedelics industry, which may prove useful to subscribers of Palm Beach Special Ops.

Bottom Line

The 3rd Trillion Dollar Trade Summit is a presentation hosted by John Burke, that features Teeka Tiwari and Mike “Zappy” Zapolin discussing the potential around investing in companies in the medical psychedelics space.

One of the companies mentioned in the presentation is called Compass Pathways, but Teeka says there are six other stocks that he is currently bullish on, which he details in two special reports.

The first report is titled “The Trillion-Dollar Trade Portfolio” which details five stocks that Teeka says are set to dominate the psychedelic medicine space in 2021. And the second is called “The Trillion-Dollar Pre-IPO” which details one pre-IPO company he’s interested in.

In order to access those reports, however, and learn about the companies Teeka and Zappy recommend, you need to subscribe to Palm Beach Special Opportunities. Which costs either $2,000 or $4,000 per year depending on which page you join through.

As part of the Palm Beach Special Ops service, subscribers get access to monthly stock picks and detailed analysis on the opportunities Teeka and Zappy are interested in each month.

All in all, it looks like a legitimate and potentially promising service. Especially since Teeka and Mike are heading it up, because they are both experts in their respective field.

That said, there are no guarantees you’ll get rich or that you’ll make 100 years worth of stock market gains in 18 months or less. And there are no cash refunds on the service.

So I personally wouldn’t rush into it without understanding the risks involved, or hoping it’s a way to get rich quickly. Because, even though Teeka is known for seeking out asymmetric (low risk, high reward) opportunities, he does not guarantee you’ll make lots of money by joining.